Rapid Micro Biosystems (NASDAQ:RPID) Shares Down 0.3%

Rapid Micro Biosystems, Inc. (NASDAQ:RPID)’s stock price fell 0.3% on Monday . The stock traded as low as $0.85 and last traded at $0.85. Approximately 20,200 shares changed hands during trading, a decline of 80% from the average session volume of 102,420 shares. The stock had previously closed at $0.85.

Rapid Micro Biosystems Price Performance

The business has a 50-day moving average of $0.74 and a 200-day moving average of $0.85. The company has a market capitalization of $36.43 million, a P/E ratio of -0.70 and a beta of 1.06.

Rapid Micro Biosystems (NASDAQ:RPID) last released its earnings results on Friday, August 2nd. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.01). The firm had revenue of $6.62 million during the quarter, compared to the consensus estimate of $6.02 million. Rapid Micro Biosystems had a negative return on equity of 45.23% and a negative net margin of 204.22%. During the same quarter last year, the business posted ($0.33) EPS. Sell-side analysts predict that Rapid Micro Biosystems, Inc. will post -1.08 EPS for the current fiscal year.

Insider Buying and Selling at Rapid Micro Biosystems

In other Rapid Micro Biosystems news, CEO Robert G. Jr. Spignesi acquired 50,000 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were bought at an average price of $0.77 per share, with a total value of $38,500.00. Following the transaction, the chief executive officer now directly owns 540,012 shares of the company’s stock, valued at approximately $415,809.24. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Richard S. Kollender purchased 65,000 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was purchased at an average price of $0.77 per share, with a total value of $50,050.00. Following the completion of the purchase, the director now owns 96,718 shares of the company’s stock, valued at approximately $74,472.86. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Robert G. Jr. Spignesi acquired 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The stock was purchased at an average cost of $0.77 per share, for a total transaction of $38,500.00. Following the purchase, the chief executive officer now owns 540,012 shares of the company’s stock, valued at $415,809.24. The disclosure for this purchase can be found here. Insiders acquired 175,000 shares of company stock worth $141,850 over the last 90 days. Company insiders own 30.40% of the company’s stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.